Distribusion Technologies | $80,000,000 | (Sep 27, 2024)
Cytix | $2,143,528 | (Sep 27, 2024)
Convergence | $12,000,000 | (Sep 27, 2024)
GlycanAge
United Kingdom
- Newcastle upon Tyne, England
- 12/03/2024
- Seed
- $4,200,000
An introduction to GlycanAge®
Our modern lifestyle has drastically changed the way we live and can impact our health for better or for worse. How can you gain a more complete picture of the current state of your health?
Science has revealed a significant element that up until recently has largely been overlooked. Your biological age.
While you have no control over the process of aging chronologically, your health and lifestyle can have a significant effect on your biological age. Your biological age is therefore not necessarily the same as your chronological age. Only about 54% of biological aging is determined by your genes, with about 46% being influenced by environmental factors.
GlycanAge is a simple, ground-breaking test that analyses your glycobiology. Taking a GlycanAge® test is a vital step to improving your health. Your test results enable you to become aware of and monitor your biological age. This not only offers you an accurate insight into the current state of your health but can give you the powerful tool to make an informative decisions about lifestyle choices and changes.
- Industry Biotechnology
- Website https://glycanage.com/
- LinkedIn https://www.linkedin.com/company/glycanage-ltd/
Related People
Nikolina LaucCo Founder
United States -
San Francisco, California
GlycanAge was founded on a promise that “health care” should start with us caring about our health before we encounter a particular problem. Disease starts on a molecular level decades before we are currently addressing it, while the majority of modern disease is preventable and the earliest molecular signal is biological ageing.
GlycanAge allows you to measure & influence your longevity by looking at an entirely new part of biology. Glycan biomarkers uniquely encapsulate genetic, epigenetic and environmental factors driving longevity for every human.
SURGAR | $12,288,870 | (Sep 27, 2024)
Quorum | Undisclosed Amount | (Sep 27, 2024)
Prepared | $27,000,000 | (Sep 27, 2024)
AmpUp | $15,000,000 | (Sep 27, 2024)
HighFive | $250,000 | (Sep 27, 2024)
Tetrix | $5,000,000 | (Sep 27, 2024)
The Curling Group | $5,000,000 | (Sep 27, 2024)
AminoChain | $5,000,000 | (Sep 27, 2024)
Gladly | $40,000,000 | (Sep 27, 2024)